Navigation Links
Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
Date:3/10/2009

-3.75 0.47 5.53 8.94 p = 0.002 WASO -1.86 -12.69 -14.31 -33.22 p = 0.001 TST -9.22 4.17 0.56 27.61 p < 0.001 Total Time Awake 9 -4.08 -1.42 -28.31 p < 0.001 Sleep Efficiency -1.94 0.82 0.14 5.80 p < 0.001

The effects of ITI-007 on SWS are likely due to the ability of ITI-007 to potently antagonize 5HT2A receptors at low doses. The expanded pharmacological effects that emerge at higher doses contributed to the robust decreases in WASO at the 10 mg dose of ITI-007. The magnitude of this effect on WASO is larger than that seen with selective 5HT2A receptor antagonists and may be attributed to additional beneficial pharmacology that emerges at the higher doses tested. The highest dose tested (10 mg) is thought to fully occupy 5HT2A receptors while adding incremental amounts of dopamine receptor and serotonin reuptake transporter (SERT) occupancy. Together, these data suggest that ITI-007 induces a novel pattern of sleep improvement.

Doses of ITI-007 were safe and well-tolerated in patients with insomnia. The majority of the subjects experienced no adverse events (58%) or adverse events that were considered unrelated or unlikely related to study treatment (26%). Only 3 of the 19 subjects (16%) experienced an adverse event considered possibly related to study treatment; these were mild to moderate, were not dose-related and all resolved. No serious adverse events were reported. Importantly, ITI-007 did not impair next day cognition as measured by a battery of cognitive testing in the morning upon waking. ITI-007 caused no significant impairment of attention, vigilance, information processing or declarative memory as measured by the Leeds Psychomotor Battery, Digit Symbol Substitution Test or Word Pair Associates Test. Pharmacokinetic analyses
'/>"/>

SOURCE Intra-Cellular Therapies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)
2. PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprovas Enantiomers of DOTAP Chloride in Immunotherapies
3. NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies
4. MaxCyte Introduces the GT(TM) Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies
5. GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis C
6. Old and new therapies combine to tackle atherosclerosis
7. Pipeline for Breast Cancer Therapies is Focus of New MedPredict Report
8. Cytochroma and Mitsubishi Tanabe form partnership for chronic kidney disease therapies in U.S. and Asia
9. 18-Month Extension of Reimbursement Rates for Radioimmunotherapies Becomes Law After Congressional Override of Presidential Veto
10. Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months
11. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 Proove Biosciences , the ... presenting research on the association between specific genes and ... Psychiatric and Mental Health Congress’ 27th Annual Scientific ... on the theme of ‘Embracing Change.’ Mental health, and ... landscape. From the challenges presented by the Affordable Care ...
(Date:9/23/2014)... San Jose, California (PRWEB) September 23, 2014 ... – Agricultural biotechnology is gaining steady popularity the ... sophisticated plant breeding techniques. Growth in the marketplace ... Genetically Modified (GM) crops in developing countries. Several ... 30% of under-nourished population, have already implemented genetically ...
(Date:9/23/2014)... This is a professional and ... Isopropanol (IPA) industry. The report provides a basic ... industry chain structure. Global market analysis and Chinese ... on history, developments, trends and competitive landscape of ... Chinese situation is also offered. , The report ...
(Date:9/23/2014)... Marktech Optoelectronics has introduced the MTE280xxx series, its ... 280 nm wavelength range. This series joins Marktech’s current ... to 405nm. These new devices are suitable for applications ... Mark Campito, Marktech’s CEO states that “what makes this ... that we offer it in one of the largest ...
Breaking Biology Technology:Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 2Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3Marktech Introduces its New Line of Deep UV Emitters 2
... Split Effective at Close of Business Today ... - VGNI Stock Symbol to Change to VRGE, PLANTATION, ... majority-owned subsidiary,of Viragen, Inc. (OTC Bulletin Board: VRAI), today announced that ... outstanding common stock,will become effective at the close of business today, ...
... 4, Dow AgroSciences LLC, a wholly owned subsidiary,of ... and Exelixis Plant Sciences, a,wholly owned subsidiary of ... the companies have signed a major research collaboration ... Dow AgroSciences,affiliate Agrigenetics Inc. The agreement is focused ...
... forum for the global pharma/biotech industries, Pharmaceutical Manufacturing and Biotechnology Middle ... ... DUBAI, United Arab Emirates, Sept. 4 The Middle East,market for pharmaceutical ... growth in double digits. The market,drivers are: -- Dubai is the ...
Cached Biology Technology:Viragen International to Reverse Split Its Common Stock 2Viragen International to Reverse Split Its Common Stock 3Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation 2Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation 3
(Date:9/23/2014)... National Institutes of Health will award funds to support ... Screening program to improve ways of predicting drug safety ... refine existing 3-D human tissue chips and combine them ... functions of the human body. Led by the National ... support 11 institutions at $17 million in 2014 with ...
(Date:9/23/2014)... announced today that the Company has secured $21 million ... be used to expand the Company,s cancer immunotherapy pipeline ... investor Yuan Capital led the round, with participation from ... Ventures, Suma Venture and Harbinger Venture Capital. , ... fully-human antibodies engineered to mimic the functions of a ...
(Date:9/23/2014)... are the same ones that were used 50 years ago. ... disease, which causes nearly 25 million people in the United ... best to take a deep breath. , But finding ... what works for one person doesn,t necessarily work for another, ... candidates often fail to mimic human responses costing tremendous ...
Breaking Biology News(10 mins):NIH funds next phase of Tissue Chip for Drug Screening program 2NIH funds next phase of Tissue Chip for Drug Screening program 3NIH funds next phase of Tissue Chip for Drug Screening program 4Airway muscle-on-a-chip mimics asthma 2Airway muscle-on-a-chip mimics asthma 3
... a great health threat, especially since routine smallpox ... treatment currently exists. In the February 1 issue ... and colleagues from Harvard Medical School propose a ... of signaling mediated by the smallpox growth factor ...
... research on prions, the infectious proteins behind "mad cow" disease ... prions in one species to infect other species depends on ... prion. Two studies on the topic appear in the 8 ... suggests that prions from one species rarely infect other species, ...
... tweaked to absorb more contaminants, researchers found that the ... results raised hopes that the plants might become a ... new research findings, published Feb. 1 in the journal ... of the Indian mustard plant, Brassica juncea, absorbed two ...
Cached Biology News:Fibril Shape Is The Basis Of Prion Strains And Cross-species Prion Infection 2Fibril Shape Is The Basis Of Prion Strains And Cross-species Prion Infection 3Transgenic plants remove more selenium from polluted soil than wild plants, new tests show 2Transgenic plants remove more selenium from polluted soil than wild plants, new tests show 3Transgenic plants remove more selenium from polluted soil than wild plants, new tests show 4
Recombinant Rat Leptin, Ultra Pure...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
Biology Products: